JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the New York Valves 2025 conference, with two live case ...

Before signing up for a race, he required a cardiologist's clearance; it was then that he discovered a life-threatening heart ...

A new study led by researchers at Penn State College of Medicine suggests that long-term use of estrogen-based hormone ...

There is decreased risk for recurrent ischemic stroke among patients aged older than 60 years in the US following patient foramen ovale closure.